Northern Trust’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,958
Closed -$21.8K 4504
2025
Q2
$21.8K Hold
3,958
﹤0.01% 4327
2025
Q1
$22.8K Hold
3,958
﹤0.01% 4327
2024
Q4
$36.6K Sell
3,958
-6
-0.2% -$88 ﹤0.01% 4304
2024
Q3
$65.2K Hold
3,964
﹤0.01% 4157
2024
Q2
$75.6K Buy
3,964
+1,152
+41% +$22.4K ﹤0.01% 4110
2024
Q1
$75.3K Buy
2,812
+62
+2% +$1.07K ﹤0.01% 4150
2023
Q4
$37.6K Sell
2,750
-835
-23% -$12.1K ﹤0.01% 4280
2023
Q3
$55.5K Sell
3,585
-38
-1% -$725 ﹤0.01% 4143
2023
Q2
$78.3K Buy
3,623
+38
+1% +$748 ﹤0.01% 4103
2023
Q1
$63.7K Buy
3,585
+15
+0.4% +$289 ﹤0.01% 4203
2022
Q4
$60.4K Sell
3,570
-46
-1% -$1.06K ﹤0.01% 4230
2022
Q3
$119K Buy
3,616
+85
+2% +$4.33K ﹤0.01% 4057
2022
Q2
$199K Sell
3,531
-37
-1% -$1.93K ﹤0.01% 3928
2022
Q1
$208K Sell
3,568
-87
-2% -$5.44K ﹤0.01% 4116
2021
Q4
$263K Buy
3,655
+136
+4% +$11.4K ﹤0.01% 4083
2021
Q3
$285K Buy
3,519
+250
+8% +$21.9K ﹤0.01% 4015
2021
Q2
$316K Sell
3,269
-12,233
-79% -$1.25M ﹤0.01% 3911
2021
Q1
$1.86M Sell
15,502
-1,618
-9% -$234K ﹤0.01% 3280
2020
Q4
$2.24M Sell
17,120
-420
-2% -$54.3K ﹤0.01% 3144
2020
Q3
$1.85M Sell
17,540
-1,462
-8% -$180K ﹤0.01% 3105
2020
Q2
$4.89M Buy
19,002
+4,748
+33% +$1.81M ﹤0.01% 2539
2020
Q1
$6.34M Buy
14,254
+410
+3% +$219K ﹤0.01% 2168
2019
Q4
$9.36M Buy
13,844
+9,717
+235% +$4.87M ﹤0.01% 2219
2019
Q3
$1.53M Buy
4,127
+2,254
+120% +$733K ﹤0.01% 3242
2019
Q2
$337K Buy
+1,873
New +$389K ﹤0.01% 3663

Other funds holding NXTC

Northern Trust's NXTC Position: Q3 2025 in Review

Northern Trust sold out of NextCure (NXTC) in Q3 2025, closing a stake of 3,958 shares — an estimated $21.8K sold.

Northern Trust first reported a position in NXTC in Q2 2019 and held it in 25 quarters. The position peaked at $9.36M in Q4 2019. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Northern Trust reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Northern Trust sold 3,958 NextCure shares in Q3 2025, an estimated $21.8K.
  • Northern Trust first reported a position in NextCure in Q2 2019 and held it in 25 quarters.
  • Northern Trust's NextCure position peaked at $9.36M in Q4 2019.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.